BackAgenus Overview
Agenus Inc

Agenus Target Price

See Agenus's analyst price targets ($25) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$8.24

Average Target Price

$25.00203.4% upside

1 analysts in the last 4 months

High: $25 | Low: $25

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-11H.C. Wainwright$25203.4% upsideOpen
2024-11-29H.C. WainwrightEmily Bodnar$715% downsideOpen
2024-07-19JefferiesBiren Amin$715% downsideOpen
2024-07-19Robert W. BairdColleen Kusy$82.9% downsideOpen
2024-07-18H.C. WainwrightEmily Bodnar$99.2% upsideOpen
2024-07-01H.C. WainwrightEmily Bodnar$20142.7% upsideOpen

Agenus (AGEN) FAQ

Agenus (AGEN) currently reports a target price of $25. Use the charts on this page to explore Agenus's target price history and peer comparisons.

Analysts' average 12-month price target for Agenus is $25, about 203.4% upside from the current share price of $8.24. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $25, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Agenus, and consider following AGEN for alerts when major investors trade the stock.

Agenus is classified in the Healthcare sector. On target price, it currently shows $25. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AGEN with unrelated industries.